Swaminathan Murugappan
- Hematology top 2%
- Oncology top 10%
- Cardiology and Cardiovascular Medicine top 5%
- Molecular Biology
- Pulmonary and Respiratory Medicine top 10%
- Co-authors
- Satya P. KunapuliHaripriya ShankarSoochong KimRobert T. DorsamG. L. PrasadBryan N. KahnerMarc PeetersAnne Thomas
- Topics
- Platelet Disorders and Treatments (12 papers)Antiplatelet Therapy and Cardiovascular Diseases (11 papers)Colorectal Cancer Treatments and Studies (8 papers)
- Partner nations
- United StatesUnited KingdomAustralia
In The Last Decade
Swaminathan Murugappan
26 papers receiving 1.3k citations
Hit Papers
Peers
Comparison fields: 5 of 100
- Hematology 458
- Oncology 382
- Cardiology and Cardiovascular Medicine 351
- Molecular Biology 336
- Pulmonary and Respiratory Medicine 204
Countries citing papers authored by Swaminathan Murugappan
This map shows the geographic impact of Swaminathan Murugappan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Swaminathan Murugappan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Swaminathan Murugappan more than expected).
Fields of papers citing papers by Swaminathan Murugappan
This network shows the impact of papers produced by Swaminathan Murugappan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Swaminathan Murugappan. The network helps show where Swaminathan Murugappan may publish in the future.
Co-authorship network of co-authors of Swaminathan Murugappan
This figure shows the co-authorship network connecting the top 25 collaborators of Swaminathan Murugappan. A scholar is included among the top collaborators of Swaminathan Murugappan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Swaminathan Murugappan. Swaminathan Murugappan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 2 | |
| 3 | 2 | |
| 4 | 1 | |
| 5 | Panitumumab versus cetuximab in patients with chemotherapy-refractory wild-type KRAS exon 2 metastatic colorectal cancer (ASPECCT): a randomised, multicentre, open-label, non-inferiority phase 3 studybreakdown → | 339 |
| 6 | 17 | |
| 7 | 4 | |
| 8 | 50 | |
| 9 | 59 | |
| 10 | 76 | |
| 11 | 1 | |
| 12 | 158 | |
| 13 | 140 | |
| 14 | 52 | |
| 15 | 56 | |
| 16 | 86 | |
| 17 | 47 | |
| 18 | 54 | |
| 19 | 72 | |
| 20 | 17 |
About Swaminathan Murugappan
Swaminathan Murugappan is a scholar working on Hematology, Cardiology and Cardiovascular Medicine and Physiology, having authored 27 papers that have together received 1.3k indexed citations. Recurring topics across this work include Platelet Disorders and Treatments (12 papers), Antiplatelet Therapy and Cardiovascular Diseases (11 papers) and Colorectal Cancer Treatments and Studies (8 papers). The work is most often cited by research in Hematology (458 citations), Physiology (134 citations) and Internal Medicine (75 citations). Swaminathan Murugappan has collaborated with scholars based in United States, United Kingdom and Australia. Frequent co-authors include Satya P. Kunapuli, Haripriya Shankar, Soochong Kim, Robert T. Dorsam, G. L. Prasad, Bryan N. Kahner, Marc Peeters, Anne Thomas, Sergei Tjulandin and Timothy Price. Their work appears in journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.